112 related articles for article (PubMed ID: 37782975)
21. Prevalence and characteristics of patients with heart failure needing palliative care.
Arenas Ochoa LF; González-Jaramillo V; Saldarriaga C; Lemos M; Krikorian A; Vargas JJ; Gómez-Batiste X; Gonzalez-Jaramillo N; Eychmüller S
BMC Palliat Care; 2021 Dec; 20(1):184. PubMed ID: 34856953
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study.
Amedro P; Basquin A; Gressin V; Clerson P; Jais X; Thambo JB; Guerin P; Cohen S; Bonnet D
Cardiol Young; 2016 Oct; 26(7):1250-9. PubMed ID: 26980152
[TBL] [Abstract][Full Text] [Related]
23. Distinct trajectories of disease-specific health status in heart failure patients undergoing cardiac resynchronization therapy.
Mastenbroek MH; Pedersen SS; Meine M; Versteeg H
Qual Life Res; 2016 Jun; 25(6):1451-60. PubMed ID: 26563250
[TBL] [Abstract][Full Text] [Related]
24. Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study.
Ponti L; Hsu K; Damy T; Villacorta E; Verheyen N; Keohane D; Wang R; Ines M; Kumar N; Munteanu C; Cappelli F
Front Cardiovasc Med; 2023; 10():1238843. PubMed ID: 37711563
[TBL] [Abstract][Full Text] [Related]
25. Does heart failure-specific health status identify patients with bothersome symptoms, depression, anxiety, and/or poorer spiritual well-being?
Flint KM; Fairclough DL; Spertus JA; Bekelman DB
Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):233-241. PubMed ID: 30649237
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme.
Johansson I; Balasubramanian K; Bangdiwala S; Mielniczuk L; Hage C; Sharma SK; Branch K; Zhu J; Kragholm K; Sliwa K; Alla F; Yonga G; Roy A; Orlandini A; Grinvalds A; McCready T; Pogosova N; Störk S; McMurray JJV; Conen D; Yusuf S
Eur J Heart Fail; 2022 Sep; 24(9):1478-1490. PubMed ID: 35570198
[TBL] [Abstract][Full Text] [Related]
27. Clinical Implications of the New York Heart Association Classification.
Caraballo C; Desai NR; Mulder H; Alhanti B; Wilson FP; Fiuzat M; Felker GM; Piña IL; O'Connor CM; Lindenfeld J; Januzzi JL; Cohen LS; Ahmad T
J Am Heart Assoc; 2019 Dec; 8(23):e014240. PubMed ID: 31771438
[TBL] [Abstract][Full Text] [Related]
28. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire.
Capota R; Militaru S; Ionescu AA; Rosca M; Baicus C; Popescu BA; Jurcut R
Health Qual Life Outcomes; 2020 Oct; 18(1):351. PubMed ID: 33126893
[TBL] [Abstract][Full Text] [Related]
29. Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy.
Huff CM; Turer AT; Wang A
Qual Life Res; 2013 Apr; 22(3):647-52. PubMed ID: 22544415
[TBL] [Abstract][Full Text] [Related]
30. Physical and emotional symptom burden of patients with end-stage heart failure: what to measure, how and why.
Opasich C; Gualco A; De Feo S; Barbieri M; Cioffi G; Giardini A; Majani G
J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1104-8. PubMed ID: 18852581
[TBL] [Abstract][Full Text] [Related]
31. Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department.
Stubblefield WB; Jenkins CA; Liu D; Storrow AB; Spertus JA; Pang PS; Levy PD; Butler J; Chang AM; Char D; Diercks DB; Fermann GJ; Han JH; Hiestand BC; Hogan CJ; Khan Y; Lee S; Lindenfeld JM; McNaughton CD; Miller K; Peacock WF; Schrock JW; Self WH; Singer AJ; Sterling SA; Collins SP
Circ Cardiovasc Qual Outcomes; 2021 Oct; 14(10):e007956. PubMed ID: 34555929
[TBL] [Abstract][Full Text] [Related]
32. Effects of a Telehealth Early Palliative Care Intervention for Family Caregivers of Persons With Advanced Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.
Dionne-Odom JN; Ejem DB; Wells R; Azuero A; Stockdill ML; Keebler K; Sockwell E; Tims S; Engler S; Kvale E; Durant RW; Tucker RO; Burgio KL; Tallaj J; Pamboukian SV; Swetz KM; Bakitas MA
JAMA Netw Open; 2020 Apr; 3(4):e202583. PubMed ID: 32282044
[TBL] [Abstract][Full Text] [Related]
33. Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure.
Flynn KE; Lin L; Ellis SJ; Russell SD; Spertus JA; Whellan DJ; Piña IL; Fine LJ; Schulman KA; Weinfurt KP;
Am Heart J; 2009 Oct; 158(4 Suppl):S64-71. PubMed ID: 19782791
[TBL] [Abstract][Full Text] [Related]
34. Pilot study of palliative care consultation in patients with advanced heart failure referred for cardiac transplantation.
Schwarz ER; Baraghoush A; Morrissey RP; Shah AB; Shinde AM; Phan A; Bharadwaj P
J Palliat Med; 2012 Jan; 15(1):12-5. PubMed ID: 22216757
[TBL] [Abstract][Full Text] [Related]
35. Psychometric properties of the portuguese version of the Kansas City cardiomyopathy questionnaire in dilated cardiomyopathy with congestive heart failure.
Nave-Leal E; Pais-Ribeiro J; Oliveira MM; Da Silva N; Soares R; Fragata J; Ferreira R
Rev Port Cardiol; 2010 Mar; 29(3):353-72. PubMed ID: 20635562
[TBL] [Abstract][Full Text] [Related]
36. Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study.
Tower-Rader A; Szpakowski N; Popovic ZB; Bittel B; Fava A; Ospina S; Xu B; Thamilarasan M; Mentias A; Smedira NG; Desai MY
Prog Cardiovasc Dis; 2023; 80():66-73. PubMed ID: 37302651
[TBL] [Abstract][Full Text] [Related]
37. [Quality of life, depression and cognitive functions 4. Quality of life].
Rete Infermieri GISSI-HF
Assist Inferm Ric; 2009; 28(1):21-6. PubMed ID: 19462697
[TBL] [Abstract][Full Text] [Related]
38. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.
Krahn AD; Snell L; Yee R; Finan J; Skanes AC; Klein GJ
Can J Cardiol; 2002 Apr; 18(4):380-7. PubMed ID: 11992131
[TBL] [Abstract][Full Text] [Related]
39. Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Ostrominski JW; Vaduganathan M; Claggett BL; de Boer RA; Desai AS; Dobreanu D; Hernandez AF; Inzucchi SE; Jhund PS; Kosiborod M; Lam CSP; Langkilde AM; Lindholm D; Martinez FA; O'Meara E; Petersson M; Shah SJ; Thierer J; McMurray JJV; Solomon SD
Eur J Heart Fail; 2022 Oct; 24(10):1892-1901. PubMed ID: 36054231
[TBL] [Abstract][Full Text] [Related]
40. Engaging patients and families to create a feasible clinical trial integrating palliative and heart failure care: results of the ENABLE CHF-PC pilot clinical trial.
Bakitas M; Dionne-Odom JN; Pamboukian SV; Tallaj J; Kvale E; Swetz KM; Frost J; Wells R; Azuero A; Keebler K; Akyar I; Ejem D; Steinhauser K; Smith T; Durant R; Kono AT
BMC Palliat Care; 2017 Aug; 16(1):45. PubMed ID: 28859648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
